Scythian Biosciences (TSXV:SCYB) has made its first strategic purchase, the company announced on Monday (July 30). following the sale of its Latin American assets to a major Canadian cannabis licensed producer (LP). The company also revealed a listing change for its stock.

On July 17 Scythian announced a transaction with Aphria (TSX:APH) for all of its interests across the Latin American cannabis market for a price tag of C$193 million in Aphria shares paid to Scythian.

The TSX Venture-listed (TSXV) cannabis company is now eyeing an entry into the Florida market with the purchase of CannCure Investments, a Canadian company currently working on the acquisition of a stake in 3 Boys Farms, a licensed producer in the state.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Rob Reid, Scythian’s CEO, said Florida is becoming one of the “largest and fastest growing medical cannabis markets” in the US.

The prized acquisition of 3 Boys Farms includes its 40,000 square feet of greenhouses for cannabis cultivation and its licenses for retail shops. According to Scythian, the Florida producer is in the process of securing locations across the state.

Scythian drops TSXV to pursue US asset

Due to the potential entry of the US cannabis market, Scythian revealed to investors it will stop offering its stock on the TSXV and will now list on the Canadian Securities Exchange (CSE), an exchange that allows listings to hold assets in the federally illegal market.

The company told investors it expects the exchange transition will be done within the next 10 business days. Currently Scythian’s share trading is halted.

The entire deal, which also includes the acquisition of an undisclosed medical healthcare organization in Florida, consist of a package payment Scythian will initially purchase a 70 percent stake in CannCure and obtain the option for the remaining 30 percent at the same valuation.

According to the company the transaction consists of a C$93.3 million in equity from Scythian common shares, with the addition of a C$43.2 million cash investment into the company.

In order for the Scythian-CannCure transaction to complete, the investment company must close its initial 60 percent stake acquisition of 3 Boys Farms before August 31.

Scythian is also requiring CannCure to hold an option to acquire the balance of the issued and outstanding shares before the end of 2018.

Investor takeaway

Following the dump of its Latin American assets to Aphria, Scythian has elected to seek a stake in the US market which will lead it to swap public exchanges.

Florida has proved to be a worthwhile market for public cannabis operators and a tentative upcoming vote on the legalization of cannabis for adult-use could provide an even higher boost to the assets in the state.

The last available share price for Scythian was C$3.49 on July 25.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Ayurcann (CSE:AYUR) entered into a joint venture with Bazelet Group, Israel’s largest privately held medical cannabis company. Ayurcann CEO Igal Sudman shared the company’s excitement about bringing unique terpene-enriched medicinal cannabis to the Canadian marketplace. 

“Canada is a very closed-loop country, and the opportunity to bring a variety of different enhancement and technologically advanced products is very important to us. The relationship that we formed with Bazelet is going to enhance our offerings into the Canadian marketplace,” Sudman said. 

Bazelet has launched multiple lines of terpene-enriched cannabis oils; each one is specifically designed for various indications, symptoms and personal needs. The company’s terpene-enriched products are optimized for women’s health, for elderly population needs, for specific types of pains (muscle, joint, neuropathic) and for improved night sleep. 

According to Sudman, there are a lot of larger companies that have tried to do this, but none have been able to successfully bring innovation into the market. Ayurcann is rapidly forging partnerships with several companies worldwide, including Cannmart, Patient Choice and Kindred Partners.

“We’re growing the business, customer base, relationships and partnerships worldwide. We’re bringing the latest technology into Canada, and enhancing not only our company, but the investors’ value moving forward,” added Sudman. 

Watch the full interview with Ayurcann CEO Igal Sudman above.

Keep reading... Show less

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a new Florida dispensary, the Company’s 91st nationwide.

The latest dispensary, located in Winter Park , supports Trulieve’s goal of ensuring medical cannabis patients across Florida have safe, reliable access to the medications they rely on. The dispensary expands access throughout Central Florida , joining four locations throughout nearby Orlando .

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis extractor, is pleased to announce that the United States Patent and Trademark Office has granted the Company a patent pertaining to the extraction and purification of THC and CBD.

The Company believes it has developed defendable intellectual property around the most efficient methods for producing THC and CBD distillate at scale within a regulated market. Nextleaf owns 15 U.S. patents and has been issued over 80 patents globally.

Keep reading... Show less

Cannabis Company Executives share vision, answer questions live at

Virtual Investor Conferences in partnership with KCSA Strategic Communications and ATB Capital Markets today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The two-day program begins at 9:30 AM ET on Tuesday June 29 th .

Keep reading... Show less

Acquisition solidifies Canopy Growth’s leadership position in the Canadian recreational market

Canopy Growth Corporation (“Canopy”) (TSX: WEED) (NASDAQ: CGC) and The Supreme Cannabis Company, Inc. (“Supreme”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) are pleased to announce the completion of the previously announced arrangement (the “Arrangement”) whereby Canopy has acquired all of the issued and outstanding common shares of Supreme (the “Supreme Shares”).

Keep reading... Show less